共 146 条
[11]
Chiti A(2014)Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial Ann Oncol Off J Eur Soc Med Oncol/ESMO 25 801-807
[12]
Abramyuk A(2010)Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis Oncologist 15 994-1001
[13]
Appold S(2012)18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging J Nucl Med Off Publ Soc Nucl Med 53 709-715
[14]
Zophel K(2011)Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma AJR Am J Roentgenol 197 976-980
[15]
Baumann M(2012)18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma J Nucl Med Off Publ Soc Nucl Med 53 1506-1513
[16]
Abolmaali N(2012)Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value Int J Radiat Oncol Biol Phys 82 548-553
[17]
Arens AI(2009)Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer Int J Radiat Oncol Biol Phys 74 1335-1341
[18]
Troost EG(2010)Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? Eur Arch Otorhinolaryngol 267 1635-1640
[19]
Schinagl D(2012)Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3 573-589
[20]
Kaanders JH(1996)Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res 56 4509-4515